Adamis Pharmaceuticals (ADMP) Price Target Cut to $0.00 by Analysts at B. Riley

Retrieved on: 2018-03-17 20:00:00

Tags for this article:

Pharmaceuticals policy

Pharmaceutical industry in China

Science and technology in the People's Republic of China

Pharmaceutical industry of China

ADAMIS PHARMACEUTICALS CORPORATION

Adamis Pharmaceuticals

Click the tags to see associated articles and topics

Adamis Pharmaceuticals (ADMP) Price Target Cut to $0.00 by Analysts at B. Riley. View article details on hiswai:

Excerpt

<div><b>Vanguard Group</b> Inc. raised its position in Adamis Pharmaceuticals by 22.2% during the second quarter. <b>Vanguard Group</b> Inc. now owns 942,940 shares of the specialty pharmaceutical company's stock valued at $4,903,000 after acquiring an additional 171,167 shares in the last quarter. Advisor Group ...</div>

Article found on:

View Original Article